Sanofi halts late-stage trial of experimental drug, raising pressure on new CEO
Sanofi has halted a late-stage trial of an experimental drug, increasing pressure on its new CEO.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near France
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Norway's May core inflation unexpectedly rises to 3.4%, data shows
Norway's core inflation rate rose unexpectedly to 3.4% in May, according to data released.
US May federal budget deficit hits $292.6B, wider than $283.1B forecast and swinging from a $215.0B surplus a year earlier.
The US federal budget balance for May was -$292.6 billion, worse than the forecast of -$283.1 billion and compared to a previous surplus of +$215.0 billion.
WH Smith warns on profit, seeks fresh capital as Iran war hits travel spending at airports and train stations.
WH Smith warns on profit, seeks fresh capital as Iran war hits travel spend.
SoftBank's $6 billion OpenAI margin loan stalls, Bloomberg reports. The financing setback raises questions about the scale of SoftBank's investment in the AI firm.
SoftBank's attempt to secure a $6 billion margin loan from OpenAI has stalled, according to a Bloomberg News report.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.